Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study

BACKGROUND: Mesenchymal stromal cells (MSC) may serve as an attractive therapy in renal transplantation due to their immunosuppressive and reparative properties. While most studies have used autologous MSCs, allogeneic MSCs offer the advantage of immediate availability for clinical use. This is of m...

Descripción completa

Detalles Bibliográficos
Autores principales: Reinders, Marlies E. J., Dreyer, Geertje J., Bank, Jonna R., Roelofs, Helene, Heidt, Sebastiaan, Roelen, Dave L., Zandvliet, Maarten L., Huurman, Volkert A. L., Fibbe, Wim E., van Kooten, Cees, Claas, Frans H. J., Rabelink, Ton J., de Fijter, Johan W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632480/
https://www.ncbi.nlm.nih.gov/pubmed/26537851
http://dx.doi.org/10.1186/s12967-015-0700-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632480/
https://www.ncbi.nlm.nih.gov/pubmed/26537851
http://dx.doi.org/10.1186/s12967-015-0700-0

Ejemplares similares